We are ready to sell and market
Opportunities
Challenge
Cases
  • Colesevelam, a sales agent of Zhejiang Jingxin Pharmaceutical in the United States
  • The sales agent of levetiracetam from Overseas Pharmaceuticals in the United States.
  • A sterile inhalation water product from another listed company (note: the company name and product name cannot be disclosed due to confidentiality reasons), The signing of the sales contract has been completed, and the product will only be sold to the United States after the FDA's on-site inspection in July 2023